Starting May 26, 2025, manufacturers of class I medical devices and Class B and C in vitro diagnostic (IVD) medical devices must comply with the Unique Device Identification (UDI) labeling requirements under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR). More specifically, by that date the UDI carrier must be reflected on the label of devices.
The UDI system enhances traceability, patient safety, and counterfeit prevention by assigning a unique numeric or alphanumeric code to each device. This code must be displayed on the device, its packaging, or instructions for use, ensuring clear identification throughout its lifecycle.
Earlier deadlines applied to higher-risk devices, including class III and implantable devices (May 2021) and class IIa and IIb devices or class D IVD medical devices (May 2023). Manufacturers must ensure compliance by properly affixing UDI carriers and updating their labeling information if applicable.
With the deadline approaching, companies should review their labeling processes to meet regulatory requirements and avoid market disruptions.
Source: MDR, IVDR